Twist Bioscience Reports Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Twist Bioscience Corporation (TWST) Tops Q2 EPS by 15c
May 5, 2022 5:16 PM EDTTwist Bioscience Corporation (NASDAQ: TWST) reported Q2 EPS of ($1.13), $0.15 better than the analyst estimate of ($1.28). Revenue for the quarter came in at $48.1 million versus the consensus estimate of $45.25 million.
As of March 31, 2022, the company had $604.4 million in cash, cash equivalents and... More



